High HIV-1 diversity in immigrants resident in Italy (2008–2017)

01 Pubblicazione su rivista
Teresa Maggiorella Maria, Sanarico Nunzia, Brindicci Gaetano, Monno Laura, Rita Santoro Carmen, COPPOLA NICOLAMARIA, Cuomo Nunzia, Azzurri Annalisa, Cesario Francesco, Luciani8 Filippo, El-Hamad9 Issa, D'ETTORRE Gabriella, TURRIZIANI Ombretta, MAZZUTI LAURA, Poggi Alessandra, Vichi Francesca, Mariabelli Elisa, Surace Lorenzo, Berardelli Giuseppina, Picconi Orietta, Cenci Alessandra, Sernicola Leonardo, Rovetto Claudia, Fulgenzi Domenico, Belli1 Roberto, Salvi Emanuela, Di Zeo Patrizia, Borsetti Alessandra, Ridolfi Barbara, Losappio3 Ruggero, Zoboli Fabio, SCHIETROMA IVAN, CELLA ELEONORA, ANGELETTI SILVIA, CICCOZZI MASSIMO, D’Amato Stefania, Ensoli Barbara, Buttò Stefano
ISSN: 2045-2322

The proportion of new diagnoses of HIV infection in immigrants residing in Italy raised from 11% in 1992 to 29.7% in 2018. To investigate the HIV clades circulating in this community a retrospective study was performed in 557 HIV-infected immigrants living in 12 Italian cities. Immigrants originated from East-Europe and Central-Asia (11.7%), North Africa and Middle East (7.3%), South and South- East Asia (7.2%), Latin America and the Caribbean (14.4%), and sub-Saharan Africa (59.4%). More
than 87% of immigrants were on antiretroviral therapy (ART), although 26.6% of them were viremic.
A 22.0% of immigrants had hepatitis (HBV and/or HCV) and/or tuberculosis. HIV phylogenetic analysis on sequences from 192 immigrants showed the presence of clades B (23.4%), G (16.1%), C (10.4%), A1 (9.4%), F1 (5.2%), D (1.6%) and Circulating Recombinant Forms (CRFs) (33.9%). CRF02_AG represented 72.3% of the total CRFs. Clusters between immigrants and Italian natives were also present. Drug resistance mutations to NRTI, NNRTI, and PI drug classes occurred in 29.1% of ART-treated and in 12.9% of ART-naïve individuals. These data highlight the need for tailored public health interventions in immigrants to avoid spreading in Italy of HIV genetic forms and ART-resistant variants, as well as HIV co-morbidities.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma